Search:   
Total 100 Quality Articles Written by 164461 Expert Authors.

 

Browse Articles
Search Articles
Submit/Edit an Article
Get RSS Feeds
Add Free Article Content
Most Viewed
Most Emailed
Article Ratings
Read Blog
Free Email Alert
Manage Subscriptions
Authors
Publishers

UK's Original 100% Compensation
Claim Company! Learn more...


 
Home | Personal Injury Compensation | Accident | Finally Understandin ...

Finally Understanding of Stage 4 Cancer Statistics –And Improving Your Life and Total Outcomes

Submitted by GelanSimons on 2012-03-21 and viewed 4730 times.
Total Word Count: 3769
  
Rate This Article | Add Comments | Send To Friends
View Comments (0) | Publisher | Print

For most cancer patients – particularly when dealing with advanced and stage 4 cancers – focus on outcome statistics when searching for a treatment facility.


For most cancer patients – particularly when dealing with advanced and stage 4 cancers – focus on outcome statistics when searching for a treatment facility that they can put their belief in. Quality of care may be determined, but one must reach beyond the numbers to grasp a deeper understanding of how to evaluate their options and statistically improve their cancer outcomes.

By working with advanced and Stage 4 cancer’s most complex cases for more than a decade, Envita has prepared this article to provide you with physician-direct perspective on the best measures by which to compare conventional and alternative cancer centers – and determining which can best suit your needs.

Let this guide show you how to identify therapies and treatments that regularly provide statistical and biological advantages for patients suffering with various cancer types.

Cancer Treatment Statistics Can be Deceiving

For starters, “statistically significant” doesn’t always equate with improvement in your condition or life. In most cases, it is prudent to determine whether the correct factors are being considered in survival data provided, or if the numbers or “positioning” have been skewed to alter perception. For example, is “the response rate” offered for a specific cancer type’s treatment regimen short-lived or sustained with significant improvement in life quality? In many cases, cancer treatment "responses" can be fleeting. Even among patients with cancers of identical stage and type can there are often different response rates based on the specific behavior and genetic variations of each person’s tumors. This model is specifically used by cancer hospitals and drug companies but certainly comes with undeniable flaws. The mishandling of response rates is reflexive of cancer statistics as a whole.

At Envita Medical Centers, statistics remain just numbers, while our most important measures of success remain the overall quality of life and long-term survival of our patients.

Here is an Example of Static Problems Cancer Treatment - Proving the Point

Review the following example to gain a better understanding of the problems that come with “statics based” cancer results, and how a patient could be mislead:
Treatment Protocol 1 (TP1) has 35 percent rate of response while Treatment Protocol 2 (TP2) has a 75 percent rate. However, if we find TP2 is short-lived, it certainly does not mean that it is a better treatment. Moreover, if TP2 is far more toxic than TP1, it is likely that the quality of life for TP2 patients will be considerably lower.

For the record, these games of data manipulation, or “only telling only part of the story,” are done with intent. Marketers for pharmaceutical companies and cancer centers are quite aware of how their statistics will likely be considered by prospective patients.

Some entities have become extremely clever with approaches to skew their results. For example, it is not uncommon to see phraseology such as, “patients that completed our protocol.” This addition by subtraction creates exclusionary criteria so that the care center in question may remove undesirable cases from the final tally so as not to produce a disappointing number. Without knowing why certain patients who did not complete the protocol, the statistics are meaningless. All the report accomplishes is to help the center appear more successful at first glance. What it does not do, however, is improve a patient’s chances.

Organizations have become crafty when it comes to sharing enhanced results with misleading survival data – or by concealing information that is relevant. Keep in mind, if it looks to good to be true, it often is. And without specific calculation criteria, results are unreliable at best.

The Bottom Line - Patients Can Improve Their Statics and Save Their Lives with correct Cancer Treatments

In our experience, what patients seek are, quite simply, the best treatments available to help them find remission, achieve a cure, and live – no more, no less.
Perhaps it would do some good to forget about all the statistics and white papers, as data is manipulated by organizations of all sizes and reputations. That being said, there are some “game changers” that may both statistically and actually help patients achieve their most sought-after goals.

The first step is to realize that every cancer case is individualized and simply do not fit into broad categories of type and stage. For this reason, genetic and personalized immunotherapies are beginning to replace the one size fits all models – because their results are superior.

Every patient is different – including their respective cancer’s causative agents, their tumor's specific metabolism, and the way they handle side effects. There is no question that the future of cancer treatment is personalization, and Envita is leading the way.

Stage 4 Cancer Treatments Impact Statistics – Conventional and Alternative

Looking at the Standard of Care for Cancer Treatment

Report Shows Conventional Cancer Treatment Centers - Worst SEER Statistical Scores

There is a lot of fear surrounding cancer treatment. Much of this stigma comes from poor results, standardized treatment plans, abysmal side effects, no customization, disease recurrence, and of course, the loss of life.

A singular focus on tumor "response" or shrinkage is a major flaw with conventional treatment. In fact, research has shown that it does not necessarily correlate with increased survival time.

When it is said that a traditional cancer treatment has had a 20 or 30 percent success rate with late-stage cancer, it actually means that patients have only experienced a 20-30 percent "response" rate, or tumor shrinkage. This statistically has little or nothing to do with the patients' quality of life or survival time. In our opinion, this misconception is largely responsible for the poor results found in the NCI Surveillance, Epidemiology, and End Results Program (SEER) database report. The SEER web site can be accessed at seer.cancer.gov.

A Deeper Look at SEER Trends in Conventional Cancer Centers

Some cancer centers are posting how “their results are better” than the conventional system or SEER numbers. That is not hard to do, particularly as it applies to late stage or Stage 4 cancers.

Doctors Faguet and Morgan* have clearly demonstrated that chemotherapy is only 2% effective in the treatment of late-stage and Stage 4 cancer, for a 5-year survival period or better. For this reason, most centers do not dare report beyond 2-3 years let alone 5 beyond initial diagnosis – quite simply the results are not going to be in their favor.

Just to provide some perspective, Envita’s typical patient is entering our medical center 2-3 years after initial diagnosis and is often refractory to conventional and many times refractory to several alternative therapies. For this reason, Envita is extremely qualified to point out those treatments that are truly “statistic beaters” for patients. It is our contention that the sooner patients incorporate them into their treatment plans, the more likely the chance for exponential improvements to manifest beyond statistical expectations. Hereunto forward, all data discussed will be for Stage 4 cancers.

Please note that the percentages provided in the following chapters are estimates (approximates) and not exact, as each patient is different and may not respond to a particular conventional or alternative treatment. Additionally, it should be understood that various details also impact the improvements to survival outcomes and patient quality of life. The purpose of this article is not to cover every treatment offered, rather provide some important examples to provide clear perspective as well as some definitive bearings by which to assist throughout the information gathering process.
 
Part I conventional Chemotherapy

Outperforming SEER Numbers through Enhanced Conventional Treatments with Chemotherapy - 75% Improvement for Most Cancers

At Envita, we pride ourselves on providing state-of-the-art conventional and advanced alternative medicine for cancer – what we call “integrative” medicine. Two of the most common conventional therapies are chemo and radio (radiation.)

By the time most patients arrive at Envita, they are either frightened by or turned off by these traditional treatment protocols, by and large, because of their own poor experiences. And while Envita has options to help patients steer clear of these treatments – chemotherapy and radiation can play both important and effective roles when used minimally - not as the lone treatment.

Second Method to Outperform SEER Numbers with Chemotherapy

Chemotherapy is widely used by the biggest and most well-recognized hospitals as a staple for cancer treatments. However, the protocols they follow are derived from large group averages. The resultant problem with this model is that our genetic and molecular testing on Stage 4 cancer shows that 75% of patients were clearly administered the wrong chemotherapy – one wholly ineffective for their specific cancer genetics and metabolism.

As a result, these patients suffer needlessly with heavy side effects, compromised quality of life, and substandard results, all while their statistics spiral downward.

Moreover, these patients were likely being reassured, all the while, that their chemotherapy was working (at least in the short-term) or having a “response.” Really all the treatment had rendered was making the cancer and tumor more resistant.


By correctly utilizing Envita’s comprehensive strategy and implementing genetic and molecular profiling, we immediately see major improvements in drug choices and a quantum leap toward superior, long-term effectiveness. To what degree? Roughly a 40% boost to statics across the board.

We envision a future where this will be the only method by which chemotherapy will be administered. In the meantime, while pharmaceutical companies and politics have a stronghold, we will continue to see the business machine satisfied to sell huge quantities of ineffective drugs for Stage 4 cancers - maintaining the game of large protocols as the standard.

40% Average Specificity Increase with Genetic and Molecular Profiling

The second major problem with chemotherapy comes part and parcel with the all-too-typical practice of immediately administering large doses – rather than the more practical and effective technique calling for low micro doses using insulin potentiation. By directly targeting the specific cancer cells in such a manner, it is possible to achieve maximum benefit while minimizing side effects. Envita’s proprietary technique, GTF (genetically targeted Fractioned Chemotherapy), pairs molecular genetic testing and the cancer cells sugar metabolism to target them directly.

The end result is far fewer side effects coupled with a considerably higher quality of life and a greatly enhanced opportunity for long-term survival.

GTF Can Provide 75% Improvement in Life Quality and Survival Time for Stage 4 Cancer Patients

 GTF can provide a 75% overall average improvement over the SEER report for Stage 4 cancers, starting 3 years after initial diagnosis. At Envita, we customarily receive patients from 2-3 years, post-diagnosis, as most are channeled through standard methods until they have personally recognized them to be unsatisfactory.

Part II Conventional Radiation treatment

Outperforming SEER Numbers by 75-80% with Newest in Conventional Radiation Treatment

Generally speaking, radiation treatment tends to be the most misunderstood therapy treatment. Lack of understanding contributes to poor cancer patient statistics at all stages.

There are two main areas to understand with radiation:

1.  Radiation therapy is often improperly prescribed because the surgeon or other care provider uses their own treatment method – oftentimes one that is cancer approved, but not necessarily ideal for the patient. Consider, for a moment, a scenario where a prostate cancer patient would be prescribed robotic surgery or radiation seed therapy when, in fact, (if size and location are appropriate) they would respond far better to cyber knife radiation. This non-invasive technique could provide life-changing results and be done with no down time or side effects.

If they were not made aware of all their options they would likely have been faced with the standard several weeks of down time/ recovery that comes with the robotic surgery, including the plausibility of uncomfortable complications. Moreover, this was only an example of an obvious, early stage cancer with many possibilities for remission. Imagine the outcome if all the best options were not weighed in a case of Stage 4 cancer planning – it could be far worse than the extra two weeks in bed and discomfort. In fact, it could prove lethal.

It should also be pointed out about the above example, that cyber knife decreases the chance of metastasis due to the absence of surgical removal. As radiation technology improves dramatically, the key is to target the tumor(s) without administering too much whole-body radiation while keeping the immune system intact. When used correctly, extension of life and its quality therewith, can dramatically change a Stage 4 statistic – particularly when combined with targeted immunotherapy. At Envita, we have seen such methodology bring about remissions, even in late-stage disease.

2. Radiation can be an expensive proposition for a hospital or cancer groups. If they own the equipment and a billing code, they will use it. This therapy type is among the most profitable for cancer hospitals and it was estimated that Cancer Centers of America bills - as much as 600 million every 6 months in tomotherapy alone. However, just because a hospital owns a particular machine or device, does not necessarily mean it is ideal for a given patient’s condition. Rather, what we see instead are patients being administered treatments without being provided superior options that may very well be available.


It is indisputable that the wrong radiation can cause extreme side effects and a significant decline in immune function. In Stage 4 cancer, that can be devastating.
At Envita, we have top radiation oncology consultants, and access to all the latest technology in targeted, next-generation, radiation therapy including tomothearpy, cyber knife, and proton beam without being fiscally overstressed. That provides Envita the luxury of putting patients first, and having the ability to incorporate properly timed immunotherapy to improve results.

Should radiation be considered at Envita, it is done with definitive plans to knock out tumors quickly with the lowest possible total body doses, thereby leaving the immune system intact. In the past, we have helped many patients avoid surgery in early disease stages while decreasing the risk of metastasis and serious side effects. The precision of modern-day equipment is accurate within 1mm and with virtually no collateral damage.

At Envita, we implement a truly integrative and advanced approach to cancer treatment. Correct combinations are critical to helping patients improve their overall outcomes.

A Look at Improving Statistical Outcomes with Alternative Cancer Centers

Simply put, Envita Medical Centers is among (if not the most) advanced alterative cancer treatment centers in the world. Our proprietary alternative medicine methods and treatments make all the difference in the world, improving statistics across the board. We can help you evaluate what is best for your specific condition.

So what is truly the best way to compare alternative cancer centers beyond relying upon easily skewed statistics? To begin, it is wise to determining if their focus is committed to improving quality of life and survival for their patients.

How Vitamin C and Ozone Therapy as Cancer Treatments Can Enhance Statics: Up to 70% Life Quality, 50% Survival Time

Oxidative therapies should be staples in the treatment of many cancers. However, only alternative medical centers across the globe take advantage of them. Vitamin C works on many levels as a natural form of chemotherapy and, when aided with ultraviolet light, can really improve the action on other conventional treatments by increasing reactive oxygen species.

To learn more about these therapies, please visit our peer reviewed vitamin C and Ozone articles.

Overview - Why Vitamin C Oxidative Therapies Don’t Always Work

At Envita, we offer our own speed drip technology and sustained release intravenous Vitamin C delivery demonstrated to significantly outperform all others. One Envita treatment is roughly 4 times more therapeutic.

However, there are several reasons that oxidative therapy might not working on all patients – at least initially. Some tumors produce larger amounts of enzyme catalase, preventing the beneficial oxidizing effect of hydrogen peroxide produced by high-dose Vitamin C. This can widely be remedied by initially administering ozone therapy, thereby increasing Vitamin C efficacy.

The other problem that stand in the way of oxidative therapy results stems from not having enough oxygen outside the cell for the Vitamin C to produce toxic hydrogen peroxide on the tumor. Again, by using ozone properly, prior to the Vitamin C dosing, this obstacle may be corrected.

With this approach, it is possible for some patients to realize and maintain remission.

Recognizing Who’s Who in the World of Cancer Treatments by What Else - Their Treatments

You need not look further than the treatments a center offers (and the scope and range of their doctors) to determine why they may (or may not) get desirable results. Once you have, you better able to evaluate your options.

Chemotherapy Sensitivity Screening and Target Radiation

Treatments provided by hospitals and cancer centers that do heavy advertising are usually limited to their own equipment. They may own old or new – but will use them liberally, as long as they have their own billing codes.

At Envita, we provide patients with a full spectrum of options – the very best available. We personalize and tailor your treatment to help you and even work to limit chemotherapy and radiation – administering only when needed, as there are many other tools available to enhance results. In simple terms, we are the alternative medicine experts.

Other Alternative Therapies Being Researched

Most alternative centers offer a high-dose Vitamin C treatment to their patients. Some may also administer ozone therapy, depending on their state and licensure. Those are always good to see from the start.

However, during your search, you may run across things like mistletoe treatment, Resveratrol treatment, Sodium Bicarbonate treatments, and myriad supplements and teas. And while many of these therapies mentioned may have their place with correct application and setting, ultimately not one of them has been a hit cure or wonder.
Envita has been exposed to so many therapies, we are utterly confident that our personalized approach of combining idyllic treatment combinations with passionate doctors, is the key to achieving significant results - really moving the statics in your favor.
 
Deeper Look at Alternative Medicine Cancer Treatment Centers with Immunotherapy

A shrewd way to evaluate Alternative Cancer Treatment Centers is by determining the level of immunotherapy available at each given center. Here is a solid explanation of immunotherapy’s different levels that may be applied to such comparative analysis.

Entry Level immunotherapy- This is seen at most naturopathic medical practices, Chiropractor offices, acupuncturist operations, and health food stores and is most easily recognized by the administering of immune system building oral supplements, nutrition, and teas. The level of background in cancer immunotherapy can vary greatly among these providers. Nevertheless, you will find that entry level is what is most often used in combination with chemotherapy and radiation. While it does have some positive effects, it is typically offered to demonstrate a particular practice or institution is “open minded” while remaining focused on pharmaceutical-based solutions.

Middle Level immunotherapy- Administers forms of immunotherapy like intravenous high-dose Vitamin C for cancer patients. Iscador, mistle toe, Resveratrol, Sodium Bicarbonate and other homeopathic botanicals may also be included in their treatment protocols. By and large middle level is provided by Naturopathic doctors in some states, as well as by some more open-minded MDs and DOs. Oftentimes these middle level practices will offer some entry level methods as well.

Higher Level immunotherapy- Aims to potentiate various forms of chemotherapy via immunotherapy. Their providers (Dos or MDs) carry the licensure necessary to practice these methods and will likely integrate all methodologies mentioned above. Their goal is to target cancer cells while working to get the immune system functioning at a high level.

Highest Level immunotherapy- This method refers directly to the science of building vaccines derived from the patient’s own immune system to fight cancer. Cellular-based immunotherapy extracts while blood cells and expands them to more effectively battle the disease. This is akin to an “immune system transplant” of sorts and originated some 25 years ago with cytotoxic T cells. The science and methodology of this highest level continue to advance rapidly and are greatly available in countries outside the United States. That being said, a newly approved drug has just been accepted in the United States for Stage 4 prostate cancer patients.
Next Gen Immunotherapy- This is a Cellular-based immunotherapy founded upon genetic manipulation.

All methods of immunotherapy are currently offered at Envita international medical centers. And with those therapies we have the experience and training to determine ideal combinations in case-by-case scenarios.

What Most Oncologists Consider Immunotherapy and the Important Alternatives They Ignore

Cell-based immunotherapy is typically recognized domestically when a drug trial is being sponsored. By and large however, the science is typically ignored. While cytokines are referenced, conventional treatment centers continually leave them out of cancer protocols. It seems that conventional oncologists worry that their patient will be taken off normal chemotherapy treatments for an unproven alternative. This unfounded fear stands in the way of most patients fully engaging in the best treatment plan possible to fight their disease.

Stacking the Statics in Your Favor

Natural Killer Cells Treatment and Technology

Envita’s proprietary natural killer cell cancer vaccine (AAIT) is a highly efficacious treatment, providing a uniquely targeted way to fight cancer – in particular, metastatic disease. You can learn more about AAIT on Envita’s AAIT Cancer Vaccine page.

Please note, Envita’s international centers provide numerous treatments not yet available in the U.S.


The Real Goal in Any Cancer Treatment is Long Term Remission

Most of us continue to grow more savvy and aware as we are faced with an endless barrage of marketing and advertising campaigns to lure us to myriad products and services. For some reason, when we think of the medical industry, we tend to assume that they are above such practices of miscommunication and manipulation.

However, when there are billions of dollars at stake, corners are cut and data is often manipulated. Sure, we agree that doctors strive to serve their patients, but that doesn’t mean that the institution that writes their check isn’t at all motivated by the almighty dollar – something that can corrupt and contaminate the environment of care.

In other words, do not be fooled. Your life is far too valuable.

In conventional cancer treatment models, “wait and see” has become a far too common approach. After treatment is administered, patients wait to see how or even if their bodies respond to treatment - and how long the effects will last.

Oncologists use the term “remission” and not “cure,” because it is unknown whether the cancer will come back later. There still may be cancer cells left in the body, even though there is no sign of it at the time. These cancer cells, which can break out of dormancy, often account for the recurrence of disease.
 At Envita, we wish to build the best personalized treatment plan for you or your loved ones’ cancer by using the most targeted and comprehensive approaches from around the world.

No matter what route you chose, we want to personally welcome you to Envita Medical Centers and let you know we are here for you – the uncontested leaders in personalized cancer treatment. At Envita aim to continually set the bar for improving cancer statistics – one patient at a time.

Article Source: http://www.compensationsecrets.co.uk/

Stage 4 breast cancer Envita is one of the leading natural medical centers in the U.S. and abroad. Envita treats a large range of conditions, and our mainly focused areas such as cancer, For more Informations Please Visit Our www.envita.com/ Website.


 
 
Number of Ratings: 0
Rating: 0

Please login here.
Email:
Password:
Name:
Email:
Password:
Comments: